January 2026 - Pharmaceutical Market Europe

January  2026 - Pharmaceutical Market Europe
Published on 26 January 2026

Description:

Expert articles on alzheimer's disease & dementia, clinical trial barriers, early diagnosis in Europe, plus ASH 2025 hematology conference coverage and oral health links to autoimmune disease.

Preview:

29 articles from this collection:
PME January 2026
PME January 2026
2 COMMUNIQUE 2026
2 COMMUNIQUE 2026
3 Comment
3 Comment
4 EHP AWARDS 2026
4 EHP AWARDS 2026
5 Contents
5 Contents
6 News
6 News
Roche and Ascidian agree to $1.8bn neurological disease partnership
7 News
7 News
8 News
8 News
Researchers identify new major cause of inflammatory bowel disease
9 News
9 News
10 DERMATOLOGY NEWS
10 DERMATOLOGY NEWS
12 Brian D Smith Darwin’s MEDICINE McNamara’s Fallacy
12 Brian D Smith Darwin’s MEDICINE McNamara’s Fallacy
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
13 Mike Dixon With compassion
13 Mike Dixon With compassion
14 GORDON DANIELS PUTTING AI TO WORK FOR PHARMA MARKETING LEADERS OF THE FUTURE
14 GORDON DANIELS PUTTING AI TO WORK FOR PHARMA MARKETING LEADERS OF THE FUTURE
15 HEALTHCARE: How personalised healthcare will shape pharma’s role and reputation by 2030
15 HEALTHCARE: How personalised healthcare will shape pharma’s role and reputation by 2030
16-18 Clinical trials on dementia: bridging access and innovation
16-18 Clinical trials on dementia: bridging access and innovation
Across almost every sector, brands are multiplying their investment in creativity
19 PM AWARDS
19 PM AWARDS
20-21 Alzheimer’s disease – the future of diagnosis and treatment in Europe
20-21 Alzheimer’s disease – the future of diagnosis and treatment in Europe
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
22-23 Oral health and systemic disease: why they may be more closely linked than we thought
22-23 Oral health and systemic disease: why they may be more closely linked than we thought
24-26 ASH 2025
24-26 ASH 2025
Picking your omnichannel direction requires a disciplined, scientific approach
27 Connecting through the chaos – why medical affairs needs creative problem-solving
27 Connecting through the chaos – why medical affairs needs creative problem-solving
28-29 Designing healthcare AI that works for every patient
28-29 Designing healthcare AI that works for every patient
30-31 TL SYNEOS HEALTH - Scaling AI in healthcare communications: from pilots to living systems
30-31 TL SYNEOS HEALTH - Scaling AI in healthcare communications: from pilots to living systems
32 - 33  Pandemic readiness is now a financial risk test – and the UK must treat it that way
32 - 33 Pandemic readiness is now a financial risk test – and the UK must treat it that way
34-35 Communication breakdown
34-35 Communication breakdown
36 Appointments
36 Appointments
37 Appointments
37 Appointments
38 Prescient Healthcare Group acquires Uptake
38 Prescient Healthcare Group acquires Uptake
39 SAMEDAN
39 SAMEDAN
40 PME
40 PME